Pain Therapeutics Inc. (NASDAQ:PTIE), announced recently that they expect to start a Phase 1 clinical trial with ORADUR®-Hydromorphone shortly with an expectation of starting a Phase 3 trial for this product candidate in 2015.  Other programs, some of which are partnered and some of which are currently unpartnered, are progressing as well.” Pain Therapeutics Inc. (NASDAQ:PTIE) belongs to Healthcare sector. Its net profit margin is … Continue reading Best Stocks : Pain Therapeutics (NASDAQ:PTIE), Symantec (NASDAQ:SYMC), Hormel Foods (NYSE:HRL), Overstock.com Inc. (NASDAQ:OSTK), The Travelers. (NYSE:TRV)